CAS 332922-63-1

STOCK2S 26016

CAS : 332922-63-1

STOCK2S 26016 is a small molecule that interacts with the kinases of tumor cells, stabilizing their function and inhibiting their sensitivity to chemotherapeutic drugs. This drug has been shown to inhibit cell migration, which is an important step in cancer metastasis. STOCK2S 26016 also inhibits cellular transition and highlighting, as well as treatments that may be used for metastatic cancers. The localization of this drug has been shown to be in tumor cells and not in normal cells.

Formule : C₂₀H₁₉N₃O₂

Degré de pureté : Min. 95%

Masse moléculaire : 333.4 g/mol

Ref: 3D-HNA92263

STOCK2S-26016

CAS : 332922-63-1

WNK-IN-B, a cell-permeable diaminoacridine, selectively inhibits WNK signaling in mpkDCT/MOVAS by targeting SPAK/OSR1 CCT domain.

Formule : C₂₀H₁₉N₃O₂

Couleur et forme : Solid

Masse moléculaire : 333.38

Ref: TM-T29161